Regulation of expression of ABCB1 and LRP genes by mitogen-activated protein kinase/extracellular signal-regulated kinase pathway and its role in generation of side population cells in canine lymphoma cell lines

References

• Gimenez-Bonafe P, Tortosa A, Perez-Tomas R. Overcoming drug resistance by enhancing apoptosis of tumor cells. Curr Cancer Drug Targets 2009;9:320–340.
   PubMed Web of Science ®Google Scholar
• Harris AL, Hochhauser D. Mechanisms of multidrug resistance in cancer treatment. Acta Oncol 1992;31:205–213.
   PubMed Web of Science ®Google Scholar
• Baguley BC. Multiple drug resistance mechanisms in cancer. Mol Biotechnol 2010;46:308–316.
   PubMed Web of Science ®Google Scholar
• Moserle L, Ghisi M, Amadori A, et al. Side population and cancer stem cells: therapeutic implications. Cancer Lett 2010;288:1–9.
   PubMed Web of Science ®Google Scholar
• Lee CG, Das B, Lin TL, et al. A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential. Br J Haematol 2012;158:79–90.
   PubMed Web of Science ®Google Scholar
• Vega F, Davuluri Y, Cho-Vega JH, et al. Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and dissemination. J Cell Mol Med 2010;14:1532–1545.
   PubMed Web of Science ®Google Scholar
• Hadnagy A, Gaboury L, Beaulieu R, Balicki D. SP analysis may be used to identify cancer stem cell populations. Exp Cell Res 2006;312: 3701–3710.
   PubMed Web of Science ®Google Scholar
• Wu C, Alman BA. Side population cells in human cancers. Cancer Lett 2008;268:1–9.
   PubMed Web of Science ®Google Scholar
• Zhang N, Li R, Tao KS, et al. Characterization of a stem-like population in hepatocellular carcinoma MHCC97 cells. Oncol Rep 2010; 23:827–831.
   PubMed Web of Science ®Google Scholar
• MacEwen EG. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev 1990;9:125–136.
   PubMed Web of Science ®Google Scholar
• Vail DM, MacEwen EG. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 2000;18:781–792.
   PubMed Web of Science ®Google Scholar
• Nemoto Y, Maruo T, Sato T, et al. Identification of cancer stem cells derived from a canine lung adenocarcinoma cell line. Vet Pathol 2011;48:1029–1034.
   PubMed Web of Science ®Google Scholar
• Ferletta M, Grawe J, Hellmen E. Canine mammary tumors contain cancer stem-like cells and form spheroids with an embryonic stem cell signature. Int J Dev Biol 2011;55:791–799.
   PubMed Web of Science ®Google Scholar
• Yamazaki J, Baba K, Goto-Koshino Y, et al. Quantitative assessment of minimal residual disease (MRD) in canine lymphoma by using real-time polymerase chain reaction. Vet Immunol Immunopathol 2008; 126:321–331.
   PubMed Web of Science ®Google Scholar
• Hiraoka H, Minami K, Kaneko N, et al. Aberrations of the FHIT gene and Fhit protein in canine lymphoma cell lines. J Vet Med Sci 2009;71:769–777.
   PubMed Web of Science ®Google Scholar
• Arends B, Vankelecom H, Vander Borght S, et al. The dog liver contains a “side population” of cells with hepatic progenitor-like characteristics. Stem Cells Dev 2009;18:343–350.
   PubMed Web of Science ®Google Scholar
• Modok S, Mellor HR, Callaghan R. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer. Curr Opin Pharmacol 2006;6:350–354.
   PubMed Web of Science ®Google Scholar
• Gromicho M, Dinis J, Magalhaes M, et al. Development of imatinib and dasatinib resistance: dynamics of expression of drug transporters ABCB1, ABCC1, ABCG2, MVP, and SLC22A1. Leuk Lymphoma 2011;52: 1980–1990.
   PubMed Web of Science ®Google Scholar
• Tomiyasu H, Goto-Koshino Y, Takahashi M, et al. Quantitative analysis of mRNA for 10 different drug resistance factors in dogs with lymphoma. J Vet Med Sci 2010;72:1165–1172.
   PubMed Web of Science ®Google Scholar
• Yang JM, Vassil AD, Hait WN. Activation of phospholipase C induces the expression of the multidrug resistance (MDR1) gene through the Raf-MAPK pathway. Mol Pharmacol 2001;60:674–680.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Knoepp SM, Ku H, et al. Differential expression of FAK and Pyk2 in metastatic and non-metastatic EL4 lymphoma cell lines. Clin Exp Metastasis 2011;28:551–565.
   PubMed Web of Science ®Google Scholar
• Kabashima A, Higuchi H, Takaishi H, et al. Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion. Int J Cancer 2009;124: 2771–2779.
   PubMed Web of Science ®Google Scholar
• Yin L, Castagnino P, Assoian RK. ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition. Cancer Res 2008;68: 800–807.
   PubMed Web of Science ®Google Scholar
• Hu XF, Slater A, Kantharidis P, et al. Altered multidrug resistance phenotype caused by anthracycline analogues and cytosine arabinoside in myeloid leukemia. Blood 1999;93:4086–4095.
   PubMed Web of Science ®Google Scholar
• Goldie JH, Coldman AJ. The genetic origin of drug resistance in neoplasms: implications for systemic therapy. Cancer Res 1984;44: 3643–3653.
   PubMed Web of Science ®Google Scholar
• Valera ET, Scrideli CA, Queiroz RG, et al. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia. Sao Paulo Med J 2004;122:166–171.
   PubMedGoogle Scholar
• Ho MM, Ng AV, Lam S, et al. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007;67:4827–4833.
   PubMed Web of Science ®Google Scholar
• Shen H, Xu W, Luo W, et al. Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma. Exp Hematol 2011;39: 558–569.
   PubMed Web of Science ®Google Scholar